GlaxoSmithKline
NYSE: GSK
$35.89
Closing price October 3, 2023
Wednesday's top analyst upgrades and downgrades included Amazon, AMC Entertainment, Apollo Global Management, Apple, Block, Capital One Financial, Carlyle, CVS Health, Etsy, Fox, Gilead Sciences,...
8 months ago
Last Updated: 8 months ago
Friday’s additional top analyst upgrades and downgrades were on Freeport-McMoRan, GSK, Intel, L3Harris Technologies, Occidental Petroleum, Roku, Six Flags Entertainment, Spirit AeroSystems, Sprouts...
10 months ago
Friday's top analyst upgrades and downgrades included Chipotle Mexican Grill, CrowdStrike, First Solar, Fortinet, Franklin Resources, GSK, Intel, Nvidia, Shoals Technologies, Spirit AeroSystems,...
1 year ago
Last Updated: 1 year ago
Friday's top analyst upgrades and downgrades included Alcoa, Blue Apron, Brixmor Property, Enterprise Products Partners, FIGS, GSK, Healthcare Realty Trust, Nordstrom, Range Resources, Southwestern...
1 year ago
Last Updated: 1 year ago
Monday's top analyst upgrades and downgrades included Chewy, Cloudflare, Coca-Cola, Doximity, Ideanomics, GlaxoSmithKline, Micron Technology, SoFi Technologies, Teladoc Health, Twitter and Walmart.
1 year ago
Last Updated: 1 year ago
Friday afternoon's analyst upgrades and downgrades included BigCommerce, Citrix, GlaxoSmithKline, Nikola, Regeneron, Shake Shack and more.
1 year ago
Thursday’s top analyst upgrades and downgrades included Analog Devices, Activision Blizzard, BP, Clorox, EA, MGM PayPal, Square and more.
2 years ago
Last Updated: 2 years ago
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Alexion, DraftKings, Inovio, Netflix, Snowflake and more.
2 years ago
Thursday's top analyst upgrades and downgrades included Apple, Best Buy, Electronic Arts, FireEye, Match, PayPal, Qualcomm and ViacomCBS.
2 years ago
Last Updated: 2 years ago
Wednesday's top analyst upgrades and downgrades included Altria, Boeing, Coca-Cola, GlaxoSmithKline, Halliburton, Kroger, Netflix and Pioneer Natural Resources.
2 years ago
Last Updated: 2 years ago
Vir Biotechnology shares jumped on Tuesday after the firm announced that it would be expanding its late-stage COVID-19 study in conjunction with GlaxoSmithKline.
2 years ago
Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that has come under fire by both political parties in the United...
2 years ago
Last Updated: 2 years ago
Nvidia has announced it will partner with GlaxoSmithKline to apply its artificial intelligence and supercomputers for the drug and vaccine discovery process.
2 years ago
GlaxoSmithKline has announced that it is acquiring a 10% stake in the German biopharma firm CureVac.
3 years ago
There are still a lot of questions for Amarin must figure out before it gets back on track. For investors, the question is whether it is the market recovery that is lifting the stock instead of the...
3 years ago
Get Our Free Investment Newsletter